Should Intuitive Surgical Be Worried About Tiny TransEnterix?
TransEnterix (NYSEMKT: TRXC) shareholders have every reason to be excited. The U.S. Food and Drug Administration cleared the way for the company to market its Senhance Surgical Robotic System on Friday. TransEnterix held a conference call to discuss the big news on Monday morning, with its stock skyrocketing on the announcement.
Senhance will become the first system to compete head-to-head against Intuitive Surgical's (NASDAQ: ISRG) da Vinci system, which first launched back in 2000. With a new rival gunning for it, should big Intuitive Surgical be worried about tiny TransEnterix?
Image source: Getty Images.
Source: Fool.com
Medtronic plc Aktie
81,10 €
0,78 %
Eine Tendenz zu Buy-Einschätzungen bei Medtronic plc, überwiegend gegenüber Sell-Einschätzungen.
Ein Kursziel von 94 € für Medtronic plc zeigt ein leicht positives Potenzial im Vergleich zum aktuellen Kurs von 81.1 €.
